Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus

Inclusion Criteria: 1. Pathologically proven squamous cell carcinoma of esophagus . 2. Locally advanced esophageal cancer , with no operation indication 3. M1a disease defined ( AJCC 1998) , including celiac lymph node for lower thoracic esophageal cancer and cervical lymph node involvement for upper thoracic esophageal cancer 4. Subjects haven't been given neither radiotherapy nor chemotherapy before 5. Age of 18-70 6. PS ≦2 7. Hemogram : WBC≧ 4000/mm3 or ANC ≧ 2000 /mm3 and Platelet ≧ 100,000/mm3 . Biochemistry : GOT/GPT ≦ 3.5 times , Cr ≦ 1.5 mg/dl and Bilirubin ≦ 2.0 mg/dl 8. With no difficulty in eating 9. Expected lifetime ≧3 months Exclusion Criteria: 1. Invasion to surrounding organ ( T4 disease ) . 2. Distant metastasis , except M1a disease . 3. Complete obstruction of the esophagus, or patients who have the potential to develop perforation 4. Women in status of pregnancy 5. Patients who have complications exist as following: * Uncontrolled angina and heart failure, have a history of hospitalization in 3 months * A history of myocardial infarction in the past 6 months * There is a need for antibiotic treatment of acute bacterial or fungal infection * Chronic obstructive pulmonary disease, or other lung disease requiring hospitalization * Drug addiction, alcoholism and AIDS disease or long-term virus carriers * Uncontrollable seizures, or loss of insight because of mental illness